Parenteral Drug Association
  

Add 2009 PDA/FDA Joint Regulatory Conference headlines to your news reader:

Click to view RSS Feed

Or, paste the URL in the box below into your preferred RSS reader.



Web banner

2009 PDA/FDA Joint Regulatory Conference

Agenda

Securing the Future of Medical Product Quality: A 2020 Vision
September 14-18, 2009 | Renaissance Hotel | Washington, D.C.
Add to Calendar

Dr. Joshua M. Sharfstein’s opening comments at PDA/FDA 2009

Speaker Biographies



Overview

The PDA/FDA Joint Regulatory Conference offers the unique opportunity for you to join FDA representatives and industry experts in face-to-face dialogues. Each year, FDA speakers provide updates on the current state of efforts impacting the development of global regulatory strategies; while industry professionals from some of today’s leading pharmaceutical companies present case studies on how they employ global strategies in their daily processes.

Hear directly from FDA experts and representatives of global regulatory authorities, and take home best practices for compliance. You won’t find this level of direct information exchange with FDA at any other conference!

PDA is also offering an exhibition during the conference, September 14-15. The PDA Training and Research Institute (PDA TRI) will host courses immediately following the conference, September 17-18, to complement what you learn at the meeting.

Contact

Conference inquiries:
Wanda Neal,  Vice President, Programs and Registration Services
Tel: +1 (301) 656-5900 ext. 111
Email: neal@pda.org

Andrea Viera, Senior Registration and Customer Accounts Specialist
Tel: +1 (301) 656-5900 ext. 220
Email: viera@pda.org


Registration inquiries:
Patresa Day, Assistant Manager of Registration and Customer Service
Tel: +1 (301) 656-5900 ext. 115
Email: day@pda.org


PDA TRI course inquiries:

Stephanie Ko, Manager, Lecture Education
Tel: +1 (301) 656-5900 ext. 151
Email: ko@pda.org

 

Exhibition/Sponsorship inquiries:
Nahid Kiani,Vice President, Membership Services and Sales
Tel: +1 (301) 656-5900 ext. 128
Email: kiani@pda.org


For more information about obtaining a U.S. visa, visit http://www.unitedstatesvisas.gov/.

Speaker Biographies

  • PDFRabia Ballica, PhD
    Rabia Ballica, PhD, CMC/Product Reviewer, CBER, FDA

  • PDFDennis M. Bensley, Jr., PhD
    Dennis M. Bensley, Jr., PhD, Director, Division of Manufacturing Technologies, Office of New Animal Drug Evaluation, CVM, FDA

  • PDFEric Berg
    Eric Berg, Director of Supplier Quality, Amgen, Inc.

  • PDFMichael W. Bonney
    Michael W. Bonney, President and CEO, Cubist Pharmaceuticals, Inc.

  • PDFJon Clark
    Jon Clark, Associate Director For Policy, CDER, FDA

  • PDFHoward Drake
    Howard Drake, Vice President, Ompi of America

  • PDFKatherine Eban
    Katherine Eban Investigative Journalist and Author

  • PDFJohn Eltermann
    John Eltermann, Director, Division of manufacturing and Product Quality, CBER, FDA

  • PDFJoseph C. Famulare
    Joseph C. Famulare, Deputy Director, Office of Compliance, Center for Drug Evaluation and Research, FDA

  • PDFThomas Friedli, PhD
    Thomas Friedli, Managing Director Tectem, University of St. Gallen, Switzerland

  • PDFRick Friedman
    Rick Friedman, Director, Division of Manufacturing and Product Quality, CDER, FDA

  • PDFBetsy Fritschel
    Betsy Fritschel, Director, Corporate Quality and Compliance Worldwide, Johnson & Johnson

  • PDFNigel Hamilton
    Nigel Hamilton, Quality Director, Sanofi Aventis

  • PDFLothar Hartmann, PhD
    Lothar Hartmann, PhD Head of External Relations - Global Quality, Hoffmann-La Roche

  • PDFBrian Hasselbalch
    Brian Hasselbalch,Team Leader, Guidance and Policy Team, FDA/CDER/Office of Compliance

  • PDFChristian Helbig
    Christian Helbig, Manager Business Development, SCHOTT North America Inc.

  • PDFMalcolm Holmes
    Malcolm Holmes Retired [previously director Quality Assurance GSK (Glaxosmithkline)]

  • PDFKirk Huber
    Kirk Huber Executive Director and Global Head of Laboratory and Preclinical Quality Assurance, Novartis Pharmaceutical Corporation

  • PDFBrian Johnson
    Brian Johnson, Director/Team Leader of Contract Operations Quality Assurance, Pfizer Global Manufacturing

  • PDFChristopher Joneckis, PhD
    Christopher Joneckis, PhD, Senior Advisor for CMC Issues, Office of the Center Director CBER, FDA

  • PDFShane D. Killian, M.S.
    Shane D. Killian, M.S., Manager, Johnson & Johnson Pharmaceutical Supply

  • PDFDuncan Low, PhD
    Duncan Low, PhD, Scientific Executive Director, Amgen, Inc.

  • PDFAnthony Luttrell
    Anthony Luttrell, President, Raland Technologies, LLC

  • PDFMary Anne Malarkey
    Mary Anne Malarkey, Director, Office of Compliance and Biologics Quality, CBER, FDA

  • PDFSei-ichi Manabe
    Sei-ichi Manabe President, Sepa-Sigma, Inc.

  • PDFDaniel G. McChesney, M.S., PhD
    Daniel G. McChesney, M.S., PhD Director, Office of Surveillance & Compliance Center for Veterinary Medicine, FDA

  • PDFEdwin Melendez
    Edwin Melendez, Consumer Safety Officer, CDER, FDA

  • PDFKaren Migliaccio
    Karen Migliaccio, President, migliaccio Consulting, LLC

  • PDFCharles Mignosa
    Charles Mignosa, President, Business systems Architects, LLC

  • PDFPaolomi Mukherji
    Paolomi Mukherji, Manager, Clarkston Consulting

  • PDFRichard Norgard
    Richard Norgard Executive Director, Global Manufacturing Compliance, Pfizer

  • PDFStephen Notarnicola, PhD
    Stephen Notarnicola, PhD, Principal Investigator,Biogen Idec

  • PDFUlku Oktem, PhD
    Ulku Oktem, PhD, Adjunct Professor, Operations and Information Management Department, Wharton School of the University of Pennsylvania

  • PDFGerard Pearce
    Gerard Pearce, Executive Vice President, SQA Services Inc.

  • PDFMichael J. Popek, M.S.
    Michael J. Popek, M.S., Supervisory Microbiologist, Center for Veterinary Medicine, FDA

  • PDFAnurag S. Rathore, PhD
    Anurag S. Rathore, PhD, Process Development, Amgen, Inc.

  • PDFEdwin Rivera-Martinez
    Edwin Rivera-Martinez, Chief, Manufacturing Assessment and Preapproval Complaince Branch Division of Manufacturing and Product Quality, Office of Compliance,CDER, FDA

  • PDFStephan Roenninger, PhD
    Stephan Roenninger, PhD Global Quality Manager, F. Hoffmann-La Roche, Ltd.

  • PDFBarbara A. Ryan
    Barbara A. Ryan, Analyst, Deutsche Bank

  • PDFSwroop Sahota, PhD
    Swroop Sahota, PhD Vice-president of Global Quality Services, Schering-Plough

  • PDFRobert Sausville
    Robert Sausville, Supervisor, Consumer Safety,CBER, FDA

  • PDFDavid R. Schoneker
    David R. Schoneker, Director of Global Regulatory Affairs, Colorcon

  • PDFJacqueline Scott, J.D., M.L.
    Jacqueline Scott, J.D., M.L., Professor, Harrison Institute for Public Law, Georgetown University

  • PDFJoshua M. Sharfstein, MD
    Joshua M. Sharfstein, MD, Principal Deputy Commissioner, FDA

  • PDFJames Shirey
    James Shirey, Director/Team Leader, Pfizer, Inc.

  • PDFJeffrey Shuren, MD, J.D.
    Jeffrey Shuren, MD, J.D. ,Associate Commissioner for Policy and Planning, FDA

  • PDFSteven Silverman
    Steven SilvermanAssistant Director, Office of Compliance, FDA

  • PDFJames Skrine
    James Skrine, Executive Director / Site Head, Quality, Amgen, Inc.

  • PDFJaneen Skutnik
    Janeen Skutnik, Director/Team Leader of Quality & Regulatory Policy, Pfizer

  • PDFDouglas Stearn
    Douglas Stearn, Director, Division of Compliance Policy, Office of Regulatory Affairs, FDA

  • PDFWayne Taylor, PhD
    Wayne Taylor, PhD, Chairman, Taylor Enterprises

  • PDFLynn Torbeck
    Lynn Torbeck, Principal Statistician, Torbeck and Assoc., Inc.

  • PDFWallace Torres
    Wallace Torres, QuaSaR Program Leader, Hoffman-La Roche Inc.

  • PDFKimberly Trautman
    Kimberly Trautman Medical Device GMP/Quality Systems Expert, FDA

  • PDFTimothy Ulatowski
    Timothy Ulatowski, Director, Office of Compliance, CDRH, FDA

  • PDFDavid Ulrich
    David Ulrich, Distribution and Logistics QA Manager, Abbott Laboratories

  • PDFMartin VanTrieste
    Martin VanTrieste Vice President Commercial Quality, Amgen, Inc.

  • PDFGreg Walker
    Greg Walker, Director, Wyeth Pharmaceuticals

  • PDFSteven Wolfgang, PhD
    Steven Wolfgang, PhD, Consumer Safety Officer, CDER, FDA

  • PDFJanet Woodcock, M.D.
    Janet Woodcock, M.D., Director, CDER, FDA

  • PDFKlaus Wuttke
    Klaus Wuttke, DirectorGerresheimer Bunde GmbH

  • PDFVictor Yamauchi
    Victor Yamauchi, Director of Supplier Quality, Amgen, Inc.

  • PDFBarbara Zinck
    Barbara Zinck Senior Director, Corporate Compliance, Cambrex Corporation

 
From: 
Email:  
To: 
Email:  
Subject: 
Message: